{
  "author": {
    "name": "Marilynn Marchione",
    "webUrl": "/author/profile/marilynn-marchione/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 26,
    "social": [],
    "articles": [
      {
        "uri": "/2011/11/14/free-drugs-can-help-prevent-repeat-heart-attacks/",
        "title": "Free drugs can help prevent repeat heart attacks",
        "byline": "Marilynn Marchione",
        "kicker": "",
        "prettyDate": "November 14, 2011",
        "timeToRead": "5 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "Say you've had a heart attack and your insurer offered you free medicines to help prevent another one. Doctors did that in a major study and were stunned to find that only about half of patients took them.",
        "body": null
      },
      {
        "uri": "/2011/11/01/adhd-drugs-dont-raise-kids-heart-risks/",
        "title": "ADHD drugs don't raise kids' heart risks",
        "byline": "Marilynn Marchione",
        "kicker": "",
        "prettyDate": "November 01, 2011",
        "timeToRead": "4 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "New study shows Ritalin and similar medicines that millions of children and teens take to curb hyperactivity and boost attention do not raise their risk of serious heart problems.",
        "body": null
      },
      {
        "uri": "/2011/10/17/pap-test-success-reaffirmed/",
        "title": "Pap test success reaffirmed",
        "byline": "Marilynn Marchione",
        "kicker": "",
        "prettyDate": "October 17, 2011",
        "timeToRead": "5 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "Scientists advising the government say a Pap test is a good way to screen young and middle-aged women for cervical cancer, and it's only needed once every three years. But they say there is not enough evidence yet to back testing for HPV, the virus that causes the disease.",
        "body": null
      },
      {
        "uri": "/2011/10/17/worried-about-vitamins/",
        "title": "Worried about vitamins?",
        "byline": "Marilynn Marchione",
        "kicker": "",
        "prettyDate": "October 17, 2011",
        "timeToRead": "6 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "Two studies this week raised gnawing worries about the safety of vitamin supplements and a host of questions. Should anyone be taking them? Which ones are most risky? And if you do take them, how can you pick the safest ones?",
        "body": null
      },
      {
        "uri": "/2011/06/15/confronting-cancer-chances-from-cellphones-to-coff/",
        "title": "Confronting cancer chances, from cellphones to coffee",
        "byline": " Marilynn Marchione ",
        "kicker": "",
        "prettyDate": "June 15, 2011",
        "timeToRead": "5 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "You're sitting in a freshly dry-walled house, drinking coffee from a Styrofoam cup and talking on a cellphone. Which of these is most likely to be a cancer risk?",
        "body": null
      },
      {
        "uri": "/2011/04/28/cheaper-eye-drug-as-good-as-pricier-one/",
        "title": "Cheaper eye drug as good as pricier one",
        "byline": "Marilynn Marchione",
        "kicker": "",
        "prettyDate": "April 28, 2011",
        "timeToRead": "1 minute",
        "image": {
          "uri": "",
          "width": "",
          "height": ""
        },
        "authors": [
          {
            "webUrl": "/author/profile/marilynn-marchione/",
            "name": "Marilynn Marchione"
          }
        ],
        "kickerNode": [],
        "summary": "A new study shows that a cheaper drug for a common eye disease is as effective as a more expensive one approved for the condition.",
        "body": null
      }
    ]
  }
}